LYMPHOCYTOPHERESIS IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

被引:0
|
作者
ROBINSON, J [1 ]
HUBBELL, E [1 ]
FAHEY, P [1 ]
GARRITY, E [1 ]
HENKIN, R [1 ]
机构
[1] LOYOLA UNIV,MED CTR,MAYWOOD,IL 60153
关键词
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:278 / 279
页数:2
相关论文
共 50 条
  • [1] LYMPHOCYTOPHERESIS IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    FAHEY, PJ
    ROBINSON, J
    GARRITY, E
    HENKIN, R
    CLINICAL RESEARCH, 1985, 33 (04): : A856 - A856
  • [2] Treatment of idiopathic pulmonary fibrosis
    Daniels, Craig E.
    Ryu, Jay H.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (06) : 668 - 676
  • [3] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    NICOD, LP
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 125 (10) : 483 - 488
  • [4] Treatment of idiopathic pulmonary fibrosis
    Valeyre, Dominique
    Dion, Genevieve
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (02): : 367 - 381
  • [5] THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    WINTERBAUER, RH
    CHEST, 1991, 100 (01) : 233 - 235
  • [6] Treatment of Idiopathic Pulmonary Fibrosis
    Abuserewa, Sherif T.
    Duff, Richard
    Becker, Gregory
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [7] Treatment of Idiopathic Pulmonary Fibrosis
    Carlos, William G.
    Strek, Mary E.
    Wang, Tisha S.
    Patel, Harin
    Raghu, Ganesh
    Wilson, Kevin C.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (01) : 115 - 117
  • [8] IDIOPATHIC PULMONARY FIBROSIS Underestimating treatment benefit of lung transplantation for idiopathic pulmonary fibrosis
    Riddell, P.
    Eaton, D.
    Miller, A. B.
    Wells, A. U.
    Egan, J. J.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [9] Recognition and Treatment of Idiopathic Pulmonary Fibrosis
    Laurent P. Nicod
    Drugs, 1998, 55 : 555 - 562
  • [10] Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
    Sgalla, Giacomo
    Franciosa, Claudia
    Simonetti, Jacopo
    Richeldi, Luca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 771 - 777